Blood Sugar9 min read·Published November 18, 2026

Non-Fasting Blood Sugar Levels Chart: Normal Ranges

See how random, post-meal, fasting, and A1C results differ—and when a follow-up test may help.

Non-Fasting Blood Sugar Levels Chart: Normal Ranges

A non-fasting blood sugar result is taken without an overnight fast, so the number depends on when and what you ate, your symptoms, medicines, and the test method. One random glucose result alone usually does not diagnose diabetes; a clinician may use repeat or confirmatory testing.

Wondering if GLP-1 is right for you? Take the 3-min clinical quiz.

See if you qualify →

What does a non-fasting blood sugar result mean?

Non-fasting glucose means blood glucose was measured without requiring an overnight fast. A random blood glucose test may be collected at any time, while a post-meal test is interpreted based on how long it has been since eating began. 1

A carbohydrate-containing meal can raise glucose for a period after eating. The same number can mean different things if it was measured before lunch, 30 minutes after a sweet drink, or two hours after a meal. 2

A clinician also considers symptoms, medical history, medicines, and whether the result came from a laboratory or a home meter. One number is a clue, not a diagnosis. 1

What is a normal non-fasting blood sugar level?

There is no single normal non-fasting glucose number for every situation. The timing of the test matters most: random results and planned post-meal results use different clinical context. 1

The chart below shows commonly referenced thresholds for nonpregnant adults. It is general reference information, not a diagnosis or a personal glucose target. 1 2

Test or situationCommonly referenced resultHow providers use it
Random plasma glucose200 mg/dL or higher, with classic symptoms of high blood sugar or hyperglycemic crisisMay support a diabetes diagnosis in that specific clinical setting. 1
Post-meal glucoseBelow 180 mg/dL, measured 1–2 hours after a meal beginsA common goal for many, but not all, adults already living with diabetes. 2
Fasting plasma glucose100–125 mg/dL: prediabetes range; 126 mg/dL or higher: diabetes rangeRequires at least 8 hours without calories and usually needs confirmation when symptoms are absent. 1
A1C5.7%–6.4%: prediabetes range; 6.5% or higher: diabetes rangeReflects longer-term glucose exposure and may need confirmation. 1
2-hour oral glucose tolerance test140–199 mg/dL: prediabetes range; 200 mg/dL or higher: diabetes rangeUsed after a standardized glucose drink, not after an ordinary meal. 1

How to use the chart safely

200 mg/dL is an important threshold, but it is not a universal diagnosis from every non-fasting test. The diagnostic criterion applies to a random plasma glucose result with classic symptoms, such as frequent urination, unusual thirst, or unexplained weight loss, or with a hyperglycemic crisis. 1

If you have a lab report, note the collection time and whether you had eaten. For help reading a fasting result, see our normal blood sugar levels chart.

How do random, post-meal, fasting glucose, and A1C differ?

Random glucose is a snapshot taken at any time. Fasting glucose and the oral glucose tolerance test use standardized timing, while hemoglobin A1C, also called HbA1c or A1C, estimates longer-term glucose exposure. 1

A1C does not show daily highs and lows. A person can have the same A1C as someone else but very different after-meal patterns. 3

TestWhen it is collectedWhat it can help showImportant limit
Random blood glucoseAny time of dayA current glucose level; may help evaluate symptoms. 1Food timing may be unknown or variable.
Post-meal blood glucoseAt a recorded time after eating beginsHow glucose changes after a meal. 2A reading without meal timing is hard to compare.
Fasting plasma glucoseAfter at least 8 hours without caloriesBaseline glucose after fasting. 1It does not show after-meal glucose changes.
A1CNo fasting requiredAverage glucose exposure over about 2–3 months. 3Red-blood-cell conditions can make the result less reliable. 3
Oral glucose tolerance testFasting, then 2 hours after a standard glucose drinkHow the body handles a standardized glucose load. 1It is not interchangeable with an ordinary post-meal result.

Why anemia can affect A1C interpretation

Anemia can change A1C interpretation because A1C depends on red blood cells and how long they circulate. A 2023 study found that A1C values differed across several anemia types in people without diabetes. 5

Tell your clinician if you have anemia, recent blood loss, kidney disease, pregnancy, or a condition affecting red blood cells. They may rely more on direct glucose testing or use another approach. 3 5

What can make a non-fasting blood sugar reading higher or lower?

Food and timing are common reasons for a changing non-fasting glucose result. Carbohydrates, sugary drinks, alcohol, exercise, illness, stress, and some medicines can all affect a short-term reading. 2 4

  • Write down when you last ate and what you ate or drank before the test.
  • Note recent exercise, alcohol, acute illness, major stress, and sleep changes.
  • Bring a complete medication list, including steroids and diabetes medicines, to follow-up care.
  • Record whether the number came from a laboratory draw, a home meter, or a continuous glucose monitor.

Home glucose meters are useful for monitoring, but they are not identical to a laboratory plasma glucose measurement. Technique, strip storage, hand contamination, and meter limits can affect a meter result. 4

For a closer look at timing after meals, read our guide to blood sugar after eating.

When should I contact a clinician about a non-fasting blood sugar result?

Contact a clinician promptly if a non-fasting result is high and you have symptoms such as unusual thirst, frequent urination, blurred vision, vomiting, weakness, or unexplained weight loss. A clinician can decide whether you need a fasting glucose, A1C, repeat laboratory testing, or urgent assessment. 1 7

Severe illness needs urgent care, not online interpretation. Seek emergency help for confusion, fainting, trouble breathing, severe vomiting, severe dehydration, or symptoms that rapidly worsen. 7

  • What time was the sample collected, and when did I last eat?
  • Was this a laboratory plasma glucose test or a home meter reading?
  • Should I have fasting glucose, A1C, or repeat testing?
  • Could a medicine, anemia, illness, or another health condition affect my result?

What evidence-based steps can support healthier blood sugar patterns?

Healthy blood sugar patterns usually come from an overall plan, not one food or one test. Regular movement, a balanced eating pattern, sleep, follow-up testing, and treatment of related health conditions are common parts of diabetes and prediabetes care. 2 8

If you have prediabetes or type 2 diabetes, your plan should fit your medicines, activity level, food access, culture, and medical history. Our prediabetes diet guide covers practical food-pattern basics without replacing personalized care.

What about time-restricted eating?

Time-restricted eating limits daily eating to a planned time window. An 18-month study in people with type 2 diabetes examined this approach alongside glycemic control and weight management, but it cannot establish that the approach is right for every person. 6

People using glucose-lowering medicines may face safety concerns if they make major meal-timing changes without clinical guidance. A clinician can help weigh the possible benefits, risks, and medication adjustments. 2

When might weight-management treatment be part of a clinician-guided conversation at Chia?

Weight-management treatment may be worth discussing when weight goals, cardiometabolic risks, and health history point to a broader care conversation. A single non-fasting glucose result is not enough to decide whether medication is appropriate. 1 8

Tirzepatide is a dual GIP and GLP-1 receptor agonist. Mounjaro and Zepbound are FDA-approved brand products containing tirzepatide for their labeled uses; eligibility, side effects, and contraindications require clinician review. FDA labeling warns about risks including nausea, vomiting, diarrhea, pancreatitis, gallbladder disease, and a boxed warning related to thyroid C-cell tumors in rodents. 9

Semaglutide is a GLP-1 receptor agonist. Ozempic and Wegovy are FDA-approved brand products containing semaglutide for their labeled uses, with risks and contraindications that also need individualized review, including gastrointestinal side effects, pancreatitis, gallbladder disease, and the thyroid tumor boxed warning. 10

How treatment works at Chia

At Chia, we offer compounded tirzepatide as tablets or injections, with plans currently starting at $249 per month for tablets and $299 per month for injections. Compounded tirzepatide is not FDA-approved. Microdosing plans are available when a licensed provider decides they are clinically appropriate.

We also offer compounded semaglutide as injections, with plans currently starting at $249 per month. Compounded semaglutide is not FDA-approved. Microdosing plans are available when clinically appropriate, and dosing is guided and adjusted by the treating provider.

Chia treatmentAvailable formsWhat the care process includes
Compounded tirzepatideTablets or injectionOnline questionnaire, licensed-provider review, provider-guided dosing, patient portal messaging, and home delivery when prescribed.
Compounded semaglutideInjectionOnline questionnaire, licensed-provider review, provider-guided dosing, patient portal messaging, and home delivery when prescribed.

3-min quiz

Talk through your weight-management goals

A prescription requires a medical evaluation and is never guaranteed. Our providers can review whether tirzepatide or semaglutide is appropriate for your goals and health history. Chia medications are compounded by US state-licensed 503A pharmacies, and compounded medications are not FDA-approved.

Chia care is 100% online: you complete a short health questionnaire, then a licensed US provider reviews your information and prescribes only when clinically appropriate. If prescribed, medication is compounded by a state-licensed 503A pharmacy and shipped to your door.

You can begin through Chia’s online eligibility process or, when using an AI agent, through DoctorMCP at mcp.chia.health. Neither route replaces appropriate in-person or emergency care for severe symptoms.

Frequently asked questions about non-fasting blood sugar levels

3-min quiz

Start an online eligibility conversation

If weight management is part of your health conversation, a Chia provider can review your medical history and goals. A prescription requires clinical evaluation and is not guaranteed; medications are compounded by US state-licensed 503A pharmacies, and compounded medications are not FDA-approved.

References

  1. 1.American Diabetes Association Professional Practice Committee. 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026. Diabetes Care. 2026.
  2. 2.American Diabetes Association Professional Practice Committee. 6. Glycemic Goals and Hypoglycemia: Standards of Care in Diabetes—2026. Diabetes Care. 2026.
  3. 3.National Institute of Diabetes and Digestive and Kidney Diseases. The A1C Test and Diabetes. National Institutes of Health. 2023.
  4. 4.U.S. Food and Drug Administration. Blood Glucose Monitoring Test Systems for Prescription Point-of-Care Use: Guidance for Industry and Food and Drug Administration Staff. 2020.
  5. 5.Alzahrani BA, Salamatullah HK, Alsharm FS, et al. The effect of different types of anemia on HbA1c levels in non-diabetics. BMC Endocrine Disorders. 2023.
  6. 6.Rastogi S, Verma N, Raghuwanshi GS, et al. The Impact of Time-Restricted Meal Intake on Glycemic Control and Weight Management in Type 2 Diabetes Mellitus Patients: An 18-Month Longitudinal Study. Cureus. 2024.
  7. 7.Centers for Disease Control and Prevention. Diabetic Ketoacidosis. 2024.
  8. 8.U.S. Preventive Services Task Force. Screening for Prediabetes and Type 2 Diabetes: US Preventive Services Task Force Recommendation Statement. JAMA. 2021.
  9. 9.U.S. Food and Drug Administration. Mounjaro (tirzepatide) injection prescribing information. 2022.
  10. 10.U.S. Food and Drug Administration. Wegovy (semaglutide) injection prescribing information. 2024.
  11. 11.U.S. Food and Drug Administration. Compounding and the FDA: Questions and Answers. 2025.

About this article

Chia Health Editorial Team — Evidence-reviewed health education

This article is for educational purposes only and is not a substitute for individualized medical advice. Talk to a licensed clinician before starting, stopping, or changing any prescription.

AI tools may assist with research and drafting. Chia's editorial team reviews source use, clarity, treatment information, and safety framing before publication. A clinician is named only after explicit sign-off. Read our editorial standards.

Get a personalized plan

See if GLP-1 is right for your body.

Our 3-minute clinical quiz is reviewed by a US-licensed clinician. Treatment delivered to your door.

Take the 3-min quiz

Keep reading

Back to all guides